Clinical Trial Update: Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment [Phase 3]

View source ↗

Summary

A Phase 3 pharmacogenetics trial evaluated how genetic factors influence the effectiveness of torasemide and spironolactone in treating hypertension; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Spironolactone (spironolactone)
• TorasEmide

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Hypertension, Genetic Predisposition | Phase 3 | Status: COMPLETED